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ABSTRACT 
In pharmaceutical industry there are some possibilities of contamination and cross contamination because of improper cleaning of 
equipment, apparatus, processing area or the starting material, this can lead to severe hazards, therefore in pharmaceutical industry 
we can’t afford any contamination as well as cross contamination. This can be minimized by proper cleaning of equipment, 
apparatus as well as the processing area. TheIndustry wants to achieve these main goals with the help of GMP. This review focused 
on the different types of cleaning process adapted by pharmaceutical industry, how the process of cleaning validation is done. In the 
cleaning validation different critical parameter, factor, material and critical process are monitored and validated so that the cleaning 
consistency can be achieved and documented accordingly. 
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Cleaning means to make any article, piece of equipment 
and area free from dirt, marks, or any unwanted matter. 
In pharmaceutical industry there is a great need of 
cleaning of equipment apparatus and processing area. 
The improper cleaning can lead to contamination and 
cross contamination. Pharmaceutical product can be 
contaminated by various materials such as residue of 
previously used active pharmaceutical ingredient, raw 
material, cleaning agents and dust particles. The main 
objective of GMP consist prevention of contamination 
and cross contamination of materials. Therefore a 
perfect cleaning method is required for avoiding the 
possibilities of contamination and cross contamination, 
for this a validated program is required, this program is 
known as cleaning validation. “Cleaning validation is 
documented evidence which assure that cleaning of 
equipment, piece of equipment or system will obtain 
pre-determined and acceptable limits”. Cleaning 
validation helps in analytical investigation of a cleaning 
procedure. The Purpose of cleaning validation is to 
verify the efficacy of the cleaning methods for removal 
of residues of previous product, preservatives, or 
cleaning agents and microbial contaminants.
 1, 2 
Cleaning 
validation fulfills the requirement of regulatory bodies 
and maintains product quality and safety of consumer. 
When Cleaning Validation is require 
 When one is establishing initial qualification of 
cleaning method and equipment. 
 If there are some major change in a cleaning 
method are being adopted.   
 If there is a major change in master formula. 
 If the cleaning substance is changed. 
Cleaning Validation protocols
 2, 3, 4, 5, 6,7,8,9, 10 
In the cleaning protocol the cleaning validation should 
be well described, the validation protocol defines all the 
critical method/ process, equipment, personnel and area 
Raj Pal et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2018; 8(3): 138-146                
ISSN: 2250-1177                                                                              [139]                                                                            CODEN (USA): JDDTAO 
that can affect the effective cleaning. So a master 
validation plan should be prepared, that will guide the 
cleaning validation step by step. While preparing 
cleaning validation protocol some points should be 
considered. 
1. Disassembling of equipments, 
2. The pre-cleaning method which is to be used  
3. A complete detail of cleaning agent which include 
the concentration, volume of cleaning agent 
required. 
4. The flow rate, pressure, rinsing time and rinsing 
frequency should be given. 
5. Complexity and designing of equipment 
6. Training schedule of personnel’s    
Validation protocols should contain
1, 2, 3, 4 
a) Purpose of the validation study 
b) Responsible  person for validation study, like 
performer and approving authority   
c) Full description of equipment to be used in cleaning 
which include list of equipment, make model, 
capacity 
d) The cleaning cycle and their frequency for any 
equipment before and after use 
e) Detailed list of all critical steps to be monitored  
f) Selection of cleaning agent with all detail like 
solubility of material to be cleaned, safety , product 
removal limit, minimum temperature and volume of 
cleaning agent 
g) Detailed Sampling procedure  
h) Type of sampler 
i) Volume/quantity of sample 
j) Containers for sample  
k) Sampling location  
l) Sample handling 
m) Sample storage  
n) Analytical testing procedure with LOD (limit of 
detection) 
o) The rational acceptance criteria with margin of error 
and sampling efficiency 
p) Change control 





Cleaning agent is used for cleaning purpose; it may be a 
combination of detergent and water or other agent like 
chelating agents. It should have high solubility towards 
the product to be removed. The properties of cleaning 
agents are given below 
a) It should not degrade the product. 
b) It should be compatible with the equipment. 
c) It should not cause environment hazardous. 
d) It should not be a contaminant of subsequent 
product.  
e) It should easily removable and easily available and 
non toxic. 
Some example of solvent given below- 
1. Water is universal solvent which is used in 
combination with surfactants  
2. Organic solvent like acetone, methanol, ethyl acetate 
are also used 
3. We can use aqueous solution of sodium lauryl 
sulphate or  sodium dodecyl sulfate 
4. The chelants solvents can also be used (ethylene 
diamine tetra acetic acid, nitrilo tri acetic acid, 
sodium hexa meta phosphate /base sodium 
hydroxide, potassium hydroxide) 
5. We can also use some acid for example glycolic 
acid, citric acid etc. 
6. The oxidant can also be used for example sodium 
hypochlorite, hydrogen peroxide 
Personnel for cleaning 
Personnel involving in cleaning procedure should be 
trained. Training should be recorded. The person should 
have suitable working clothing to prevent spreading the 
particles and dust. The direct contact between personnel 






The buildings should be designed to minimize the 
potential contamination whether it is a cross 
contamination or microbiological. Therefore the 
designing and location of buildings and facilities should 
be constructed to facilitate the easy cleaning and easy 
maintenance.  All parts of the equipment and area can be 
easily washable to minimize or reduce the chances of 
deposition of contaminants on broken parts, groves and 
open joints of equipments. The methods, critical 
parameter like cleaning frequency and number of 
cleaning cycles and cleaning procedure must be 
validated. 
Cleaning Validation Program 
4, 5, 10
 
a) Selection of cleaning Level (Type) 
b) Selection of cleaning method 
c) Selection of sampling method 
d) Selection of scientific basis for the contamination 
limit (acceptance criteria) 
e) Selection of Worst case related to the equipment 
f) Selection of Worst case related to the product 
g) Establishing the storage period after cleaning (hold 
time study) 
h) Selection of analytical method 
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i) Documentation 
Selection of Cleaning Method 
10 
1. Manual cleaning 
2. Semi-automatic procedures 
3. Automatic procedures 
4. CIP (Clean-in-place) 
5. COP (Clean-out-of-place) 
Manual Cleaning Method 
 It is difficult to validate 
 For this extensive and detailed cleaning procedures 
are required 
 A high quality and extensive training program is 
required 
 The risk involved in manual cleaning processes is taken 
care of with following: 
 Proper washroom design with drying, protection 
and storage requirement. 
 Detailed cleaning SOPs are required 
 Training / Qualification of cleaning operators is 
required 
Clean-In-Place (CIP) Method 
 Cleaning of the equipment is performed in place 
without disassembling 
 Cleaning process may be controlled manually or by 
an automated program. 
 Very consistent and reproducible cleaning method. 
 Can be validated readily. 
 Being a closed system visual inspection of all 
components is difficult. 
Clean-Out-Of-Place (COP) Method  
 Cleaning of disassembled equipment is performed 
in a central washing machine. 
 The washing machine also requires validation such 
as the temperature, ultrasonic activity, cycle time, 
cleaning operation sequence, detergent quantity 
dispensed etc. 
Evaluation of cleaning: 
2
 
Visual Cleaning Test 
All parts of equipment which are in direct contact and 
non-contact with products should visually check and 
verified for cleanliness.  
Spiking test 
This test verifies the cleaning of equipment visibly, 
there should be no residue. A diluted series of the worst 
case are made in volatile solvent and applied on surface 
of test equipment, which is similar to the sample surface 
(e.g. 25 cm
2
). The active ingredient quantity should be 
distributed uniformly on surface of test equipment; the 
test should be performed by using different 
concentrations and also mimicking the same test 
conditions using approximate volume. The solvents are 
then evaporated to determinethe visual limit of detection 
by comparingwith the test surfaces of equipment. But 
this limit can be affected by light intensity, surface 
characteristics, and method handling by operators’ or 
operator itself. Therefore all the condition related to the 
test should properly match with the validation studies 
conditions.  This test is not performed for the materials, 
which are Generally Recognized as Safe (GRAS). 
Bracketing or Worst Case Rating
11  
In pharmaceutical industry, when we are dealing with 
two or more similar product and same process is being 
used, there is no need  to validate individual equipment 
for the similar product, to minimize the number of 
validation; a single study considering the worst case or 
bracketing approach of validation is used. 
This approach is based on scientific rationale with 
appropriate justification. First the grouping of 
substances/ products or equipment is done for similar 
product manufactured in same equipment. 
Substances can be grouped as follows  
Grouping by Product:  
The formulations are grouped on the basis of the dosage 
form for example if a company has 5 tablet 
formulations, 5 ointment formulations and 5 liquid 
formulations. They are categorized in 3 groups; these 
groups can be further classified in subgroups like tablet 
can be classified into 2 subgroups on the basis of the 
manufacturing procedure (out of 5 products 3 by dry 
granulation and 2 by wet granulation). Likewise 
ointment and liquid formulation can also be classified in 
sub groups. After establishing formulations group and 
subgroups ‘worst case’ of each group is determined. 
Grouping by Substances: 
The product are grouped or categorized as they are 
produced in the same train substances with the same 
cleaning procedure. Then they categorized in subgroup 
as they produced in the same train substances with very 
low therapeutic dose and/or low batch sizes or with very 
low/high acceptable daily exposure (Then sub groups to 
be formed based on cleaning process).  Once the product 
groups have been established the next step is determined 
the ‘worst case’ representative of each group and 
cleaning validation of the same. Same cleaning process 
is performed using same cleaning agent and other 
parameters, and thena worst case rating procedure is 
used to select the worst case, which includes: 
1) The product hardest to clean (easy, difficult or 
medium) 
2) Solubility in used solvent (soluble, very soluble, 
sparingly soluble or slightly soluble), 
3) Lowest acceptable daily exposure (maximum limit 
of drug bearable by patient on daily basis) 
4) Lowest therapeutic dose are considered as worst 
case with in group.  
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Cleaning Of Equipment:
 5, 7, 9
  
There are two types of cleaning procedure for equipment 
used in manufacturing.  
A. Type A Cleaning Procedure for equipment 
B. Type B Cleaning Procedure for equipment 
Type A Cleaning Procedure For Equipment  
All the parts of equipment are dismantledand transferred 
to washing area cleaned out of place (COP). In washing 
area the dismantled parts of equipment shall be cleaned 
with cleansing agent (i.e. 0.5% w/w SLS) or other 
cleaning aids as per procedure mentioned in their 
respective SOPs of cleaning of equipment. The non-
dismantle part of the equipment should be cleaned in 
place (CIP) as per their respective SOPs for cleaning. 
The washing/rinsing water sample should be collected 
after visually verification by production chemists and 
QA and the send to Quality Control along with sample 
request for determination of residual drug and cleansing 
agent.  
Type B cleaning for equipment is applied in the 
following conditions. 
i) Batch to batch changeover of the same product 
having same strength. 
ii) Same color  and same flavor 
iii) Batch to batch change over but from lower strength 
to higher strength. 
iv) After completion of the batch.  
v) After any minor breakdown, where product contact 
parts are not disturbed. 
vi) Cleaning done after completion of preventive 
maintenance work if product contact parts are not 
contaminated, touched and disturbed. 
vii) After any major break down where product contact 
parts are contaminated. 
viii) After completion of preventive maintenance work If 
product contact parts are disturbed/ contaminated.  
Type B cleaning procedure for equipment 
All gross accumulations from equipment and area are 
removed. Then the equipment should be cleaned without 
dismantling and dust of previous product is removed 
with the help of vacuum cleaner. Then equipment shall 
be mopped with clean moist lint free cloth (moist with 
de-mineralized water) and later with clean dry cloth.  
Instructions for Cleaning of Equipment’s 
The equipment is cleaned with help of respective SOPs 
of cleaning of that particular equipment using suitable 
nylon brush and cleansing agent. Then the cleansing 
agent is removed with potable/raw water and later rinsed 
with de-mineralized water.  Clean dry lint free cloth or 
compressed air is used to dry the equipment. After 
completion of cleaning activity, the “CLEANED” status 
labels is then labeled by the production personnel and 
attached on equipment after that the QA personnel shall 
verified only after inspecting the equipment visually for 
cleanliness. Line clearance of equipment should be 
made by visually examine the equipment and should be 
found satisfactory if not found then repeat the clean for 
same. 
Hold Time for Cleaning 
5, 6, 7, 12
 
Clean Hold Time is time duration between the 
completion of cleaning and the initiation of the next 
manufacturing operation. If hold time is not determined 
the cleaning of equipment vary from standard procedure 
and harder to clean, because the dirt on equipment 
becoming sticky as hold time increases. So hold time for 
cleaning must be evaluated. 
Generally the Clean hold time for unclean should not be 
more than 72 hrs and for cleaned equipment it should 





The area shall be cleaned according to the following 
types: 
Type A cleaning for area  
The whole room from ceiling to walls progressing to 
downwards including pallets, trolleys SOPs stand, 
accessories box weighing balance, air handling unit 
(AHU) supply/return grilles switchboards, utility 
pendants should be cleaned by using the vacuum cleaner 
and wiped with vacuum cleaner. Then the waste 
materials are collected, put into suitable poly bags and 
tied up, then accordingly labeled and sent to the scrap 
area. The entire room is cleaned with potable water and 
rinsed with de-mineralized water, and then dry duster is 
applied, and cleaned with disinfectant solution using wet 
duster or lint free cloths. All item present in room are 
mopped with dry duster and then with wet duster using 
disinfectant solution. The drain points are cleaned and 
sufficient volume of disinfectant is poured. The whole 
cleaning activity should be recorded in the cleaning 
record log book and specific log book of item present in 
the room. 
Type B cleaning for area 
All the dust and gross accumulations from equipment 
and area removed. Then the waste material is collected 
and put in suitable poly bags then tied up, labeled and 
sent to scrap area. The dust from the whole room from 
ceiling to walls progressing to downwards including 
pallets, trolleys SOP stand accessories box weighing 
balance air handling unit (AHU) supply/return grilles 
switchboards is removed using the vacuum cleaner and 
wiped with vacuum cleaner. The waste material is then 
collected, put into suitable poly bags, tied up, labeled 
and then sent to scrap area. All item present in room are 
mopped with dry duster and then with wet duster using 
disinfectant solution. The drain points are cleaned and 
sufficient volume of disinfectant is poured. The whole 
cleaning activity should be recorded in the cleaning 
record log book and specific log book of item present in 
the room. 
Cleaning record  
Cleaning activity should be recorded in approved log 
book for cleaning of equipment; room and specific log 
book of item present in that particular room are then 
signed with date by the operator and person responsible 
for that area. 
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Sampling techniques 
13     
 
Sampling techniques can be used for collecting the 
samples from the equipment  
1. Rinse Sampling. 
2. Swab Sampling. 
Swab sampling 
1. Swab sampling is used to determine previous 
product residue. 
2. Microbial Analysis of Swab Samples 




It is also known as direct surface sampling method. This 
method is based on the physical removal of residue left 
over a piece of equipment after it has been cleaned and 
dried. A swab with a solvent is applied over a surface to 
remove any residue, and extracted into a known volume 
of solvent in which the contaminant active ingredient 
residue is soluble. The amount of contaminant per swab 
is then analyzed by an analytical method of high 
sensitivity. 
Advantages of swab sampling 
1. It physically removes insoluble or poorly soluble 
substances from the equipment surfaces. 
2. It is direct evaluation of equipment surface 
contamination. 
3. Adaptable to wide variety of surfaces. 
4. Economical and widely available. 
 Disadvantages of swab sampling 
1. This techniquemay introduce fibers. 
2. It is technique dependent of sampler. 
3. Difficult to implement in complex and large 
vessels, pipes, valves etc. 
Swab sampling:  
Sampling Location and Number of Samples
10, 14 
The sample locations are dictated by worst-case 
conditions. The equipment’s hard to clean locations are 
identified based on cleaning experience and the design 
of equipment. The number of samples should be taken 
into consideration, the equipment surface area, design, 
shape, operating principle and construction material. 
Sample Surface Area 
16 
The swab sampling technique is used wherever 
swabbing of equipment surface area is accessible. After 
unloading final rinse from the equipment, the swab 
samples are collected from the selected critical areas 
where the possibilities of contamination are more. The 
fixed quantity of disorbent is taken to collect the swab 
sample (Disorbent used for swab sampling shall be the 
cleaning agent in final rinse). The swab samples 
arecollectedwith the help of swab sampler from the 
equipment surface area (25-100 sq.cm) and dip in to the 
disorbent. The swabs are collected in sample bottle from 
all the critical sampling points and send for analysis. 
Swab sampler should- 
1. Swab should be compatible with the product. 
2. It should allow extraction of the compound for 
analysis. 
3. Swab should not release fibers 
Fixing limits for sample: 
 Limit in Swab analysis:  
   
                 
       
                                            eq.1 
S = Allowable limit in Swab sample 
MAC = Maximum Allowable Carryover 
RF = Recovery Factor  
1000 = Conversion Factor in to PPM 
SA = Swabbed area for individual equipment.  
TSA = Total shared surface area of non-dedicated 
Equipment. 
DV = Disorbent volume. 
RF: Recovery factor  
The recovery of the extraction process is validated by 
spiking the analyte at known concentration to determine 
the recovery. The recommended recovery is 80%, less 
than 80% is needs justification. Piece of the equipment 
use to study recovery factor should be same material of 
construction of equipment used for the process.There 
should be evidence that samples are accurately 
recovered. 
For example, a recovery of >80% is considered good, > 
50% reasonable and< 50% questionable. 
 % recovered by the swab  
 
                              
                              
                              eq.2 
b)  Microbial Analysis of Swab Samples from 
Equipment Surface in Production Area
17 
 
The method of analysis of swab sample for total 
microbial count, yeast mold count and pathogens is 
given below.  
Total Microbial Count:  






The swab is aseptically moistened for not more than 2 
hours prior to use by a technician in a bio-safety 
chamber. The swab is aseptically removed from the 
plastic applicator tube with taking care to not touch with 
the shaft or the swab tip, the plastic tube is kept such a 
way that it remains clean and sterile.The swab with the 
sterile diluents pressed against the side of the diluents 
bottle to remove the excess diluents, leaving the swab 
moist, not saturated and then the swab is placed 
aseptically to the plastic applicator tube.  
Procedure for Microbiology Swabbing Method 
14
 
The production chemist/QC personnel remove the swab 
aseptically from the plastic applicator tube, without 
touching the shaft or the swab tip and also the plastic 
tube is kept clean, sterile and handled as little as 
possible. A 10cm
2
nylon template previously wiped with 
70% isopropyl alcohol is placed over the area to be 
sampled, to ensure that the correct surface area is 
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swabbed. The moistened swab is placed on the test site 
and sampled across the entire selected surface. The swab 
should be hold at a slight angle to the surface and slight 
pressure is applied.  The angle and pressure should be 
such as to allow as much contact between the swab head 
and surface as possible, without damaging the swab. 
The surface should be sampled using parallel strokes 
from right to left (horizontally) from top to bottom of 
sampling area, rolling the swab approximately 180
0
 in a 
clockwise direction, ensuring the previously swabbed 
area is slightly overlapped. It should be ensured that the 
entire surface of the swab head comes into contact with 
the surface. This procedure is then repeated same 
vertically, i.e. at 90
0 
to the initial swabbing. Then 
repeated diagonally, i.e. at 45
0 
to the initial swabbing, 
the swab is then returned aseptically to the plastic 
applicator tube for QC/Microbiology laboratory for 
further processing.   
Swabbing/ Sampling Method of an Irregular Surface 
15
 
Swab samples are assigned a unique sample number in 
QC. 4 sterile Petri dishes are taken and 1 ml of the 
sample is taken into each Petridis. In two Petridis, 20 ml 
of sterile, molten soybean casein digest agar is added 
and cooled to 40‐45ºC and allowed to set. Then in 
remaining two Petri dishes, 20 ml of sterile, molten 
sabourauds and agar is added and cooled to 40‐45ºC and 
allowedset. The soybean casein digest agar plates are 
incubatedat 30‐35ºC for 5 days and sabourauds-agar 
plates also incubated at 20‐25ºC for5 days.After the 
incubation period, the numbers of colonies arecounted. 
Yeast and Mold Count:  
For determination of yeast and mold count the previous 
method for total microbial count is followed except the 
medium. In this case sterile, molten potato dextrose agar 
is used.  
Test for E. coli:  
1ml of the sample in 5ml of sterile nutrient broth is 
incubated at 37ºC for 24 hrs(enrichment culture I),  1ml 
of this, is transferred to a sterile tube containing 5ml of 
MacConkeys broth and an inverted Durham tube, and 
incubate  for 48 hrs at 35‐37ºC . If the tube do not turns 
yellow and gas bubbles are not seen in the Durham tube 
this shows absence of E. coli., if this happens this shows 
presence of E. coli., then the secondary testcarried out in 
which 1ml of sample is added tube (a) containing 5ml of 
MacConkeys broth and an inverted Durham tube and 
tube (b) containing 5ml of peptone water, both the tubes 
are incubated for 24 hours at 43.5-44.5 º, and tube (a) 
observed for acid and gas production and tube (b) for 
indole. For indole testing 0.5ml Kovac’s reagent added 
and shaken well and allowed to stand for one minute, if 
a red color layer is observed it indicate presence if E. 
coli. 
Test for Salmonella:  
1ml of enrichment culture-I is transferred to two sterile 
test tubes, each tube contains 10ml Selenite F broth and 
Tetrathionate Brilliant Green Bile Broth,then the  tubes 
are incubated at 37ºC for 24 hrs. Then a loopful of the 
contents taken from tube and transferred to any two of 
the following media (1) Brilliant Green Agar (2) 
Bismuth Sulphite Agar, (3) Xylose Lysine Deoxycholate 
Agar, (4) Deoxycholate Citrate Agar, and incubated at 
35‐37ºC for 24 hrs, the presence of Salmonella colony is 
observed, if there is no colonies then test is complies for 
absence of Salmonella.   
Test for Staphylococcus aureus: 
1ml of the sample was taken to 100 ml of sterile 
Soybean Casein Digest Medium (enrichment culture II) 
and incubated at 35‐37ºC for 24 hrs. Then a loopful of 
enrichment culture II transferred to sterile pre-incubated 
plates of Vogel Johnson agar, mannitol salt agar and 
Baird Parker agar and then observed for colonies of S. 
aureus. If there is presence of colonies the coagulase 
tests is done for confirmation of S. aureus. In this test, a 
colonytransferredinto a tube having 0.5 ml of 
mammalian plasma and incubated on water bath at 37ºC 
for 24 hrs. Ifthe coagulation occurs, this shows the 
presence of S. aureus.  
Test for Pseudomonas aeroginosa: 
A loopful of enrichment Culture II is streaked out and 
transferred to a pre-incubated plate of sterile cetrimide 
agar and incubated for 24 hrs at 35‐37ºC and the 
presence of colonies is observed, if there colonies are 
seen, then confirmation pigment test is carried out. For 
this a colony is taken out on sterile Petri dish of 
pseudomonas agar for detection of fluorescein and 
pyocyanin. The Petri dish is incubated at 33-37ºC for 
minimum 3days. The Petri dish are then examined under 
UV light and looked for colonies, To detect oxidase, 2–3 
drops of fresh prepared solution of 1% N, N, N1, 
N1‐tetra methyl‐4 –phenylene diamine dihydro chloride 
placed on a filter paper and smear with the suspect 
colony. If the pink color changed to purple, which 




The swab is placed into bio-safety cabinet, a sterile tube 
containing 2mL sterile saline. The handle of swab 
isaseptically broken. Then the tube is vortexed at high 
speed for 2 minutes, and after this 1ml is transferred to a 
sterile Petri dish, 20ml molten TSA media is added to 
the Petri dish, and properly mixed with sample. TSA is 
cooled, solidified, inverted and then incubated at 30-
35
0
C for 5 days. The number of colony forming unit are 
counted and recoded, with the help of Colony Counter. 
0.5ml of the liquid of vortexed tube is added to 9ml of 
TSB in a sterile tube and incubate (enrichment step) at 
30-35
0
C for 5 days. After incubation, 0.1ml of the broth 
is streaked onto pseudomonas-CFC selective agar plates 
and MacConkey agar plates to find out the 
presence/absence of coliforms/pseudomonas. The 
pseudomonas-CFC agar plates is incubated at 20-25
0
C 
for 48 hrs, the grown colonies are suspected as 
pseudomonas spp. and then counted and confirmedby 
using Gram staining and Vitek-II system. The 
MacConkey agar plates are incubated at 37±1
0
C for 48 
hrs, the grown colonies are suspected as coliforms and 
are counted and confirmed by using Gram staining and 
Vitek-II system. 
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Swab Negative Control 
The negative control is prepared by inoculatinga 
separate swab directly with the sterile diluents with the 
same volume (0.1ml) asused to moisten the test swab 




a) Absence of Coliforms and Pseudomonads  
b) The total microbial count should not be more than 
100 CFU/100 cm
2
, fungi count should not be more 
than 10 CFU/100 cm
2 





The rinse sampling technique is used for large vessels, 
hoses etc., (reactors, pumps, big equipment etc.). The 
entire equipment surface area rinsed with fixed quantity 
of the cleaning agent. The cleaned and dried sample 
bottle is taken and the sample is collect from the 
equipment. 
Advantages of rinse sampling 
a) Easy to sampling  
b) Allows sampling of a large surface area and porous 
area. 
Disadvantages of rinse sampling 
a) Residues may not be distributed homogeneously. 
b) Inability to detect location of residues.  
c) Rinse volume is critical to ensure interpretation of 
results. 
d) Insolubility of residues and residues 
e) Physically occluded in the equipment 





     S  
              
  
                                       
eq.3 
Here:  
S = Allowable Limit in Rinse Sample in PPM. 
MAC = Maximum Allowable Carryover 
RF = Recovery Factor. 
V = Volume of solvent used for final rinse for all 
equipment 
Calculation of Acceptance Criteria 
21, 22, 23
 
a) Health-based data 
b) LD50 
c) Therapeutic Daily Dose 
d) General Limit as acceptance criteria 
a) Health-based data  
ADE 
           
             
                                              eq.4 
MACO 
                                      
       
                      eq.5 
MACO-Maximum Allowable Carryover: amount from 
the previous product into next product (mg)  
ADE-Acceptable Daily Exposure (mg/day)  
NOAEL -No Observed Adverse Effect Level 
(mg/kg/day) 
BW -Is the weight of an average adult (e.g. 70 kg)  
MF- Modifying Factor:  factor -uncertainties not 
covered by the other factors  
PK- Pharmacokinetic Adjustments  
UFc- Composite Uncertainty Factor: factors which 
reflects the inter individual variability, interspecies 
differences, sub-chronic-to-chronic extrapolation. 
TDDnext - Standard Therapeutic Daily Dose of next 
product (mg/day)  
MBSnext Minimum batch size of next product(s) (where 
MACO can end up) (mg) 
b) Based on LD50  
NOEL number (No Observable Effect Level) can be use 
for to determine MACO.    
NOEL 
       
    
                                               eq.6 
From the NOEL number a MACO can be calculated 
according to:    
MACO Maximum Allowance Carryover: acceptable 
transferred amount from the previous product into your 
next product (mg) 
MACO 
                    
                  
                                   eq.7 
BW is the weight of an average adult  
2000 2000 is an empirical constant 
NOELprevious No Observed Effect Level (mg/day)  
LD50 Lethal Dose 50 in mg/kg animal.  
TDDnext Standard Therapeutic Daily Dose of the next 
product (mg/day) 
MBSnext Minimum batch size of the next product (s)  
SFnext Safety factor   
c) Based on Therapeutic Daily Dose  
Apply when we have limited toxicity data.  
Maximum Allowable Carryover (MACO).  
MACO 
                   
                  
                                           
MACO Maximum Allowance Carryover (mg)                                            
TDDnext  Standard Therapeutic Daily Dose of the next 
product (mg/day)  
MBSnext Minimum batch size of the next product(s) 
(where MACO can end up (mg 
TDDprevious Standard Therapeutic Daily Dose of the 
investigated product 
SF Safety factor  
Safety factors:  
Topical 10 – 100 
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 Oral products 100 – 1000 
Parenterals1000 – 10 000                        
d) General Limit as acceptance criteria  
Upper limit for the maximum conc. (MAXCONC) of a 
contaminating product. 
 
                                                         
eq.9 
MBS Minimum batch size of the next product(s)       
MACOppm Maximum Allowable Carryover:       
MAXCONC maximum allowed conc. (kg/kg or ppm) 
of previous product in the next batch.  
Analytical Method Selection 
24
 
There various analytical method are available which can 
used in validation of cleaning process  
1. The Analytical Method is selected on the following 
basis. 
2. The method should be highly sensitive to calculate 
the contamination limit. 
3. It should be fast and practically performable, with 
in house instrument  
4. A validated analytical method in accordance to 
ICH, USP and EP should be used. 
Specific Method 
In specific method we can use the chromatographic 
technique to analyze the residue or contamination 
because they arehighly specific, sensitive, and also 
quantitative method. These methods are very expensive 
and tedious.For example gas chromatography, High 
Performance Liquid ChromatographyTLC,etc. 
Chromatographic methods are the methods of choice. 
Non-Specific Method  
In specific method UV/visible spectrophotometric or 
infrared spectrophotometric methods are used the 
visible. The cleaning procedure is monitored by 
usingtotal organic count(TOC) method. It is cost 
effective and rapid;it has lowest detection limit (parts 
per billion). 
Documentation 
The whole cleaning procedure is then 
documented.These documents include validation 
protocol, SOPs, reports. The cleaning process is 
complextherefore the number of document may vary; all 
the critical steps in cleaning are documented. The 
document should carry detailed information about 
cleaning of equipment, which includesthe person who 
will clean it, cleaning schedule, previously used product, 
cleaninghistory, limits of residue after cleaning, test 
results and acceptable limits. The operator performance 
and effectiveness of the process is evaluatedand if 
theperformance of operator is not upto the mark, for this 
guidelines and training schedule are required and 
documented. Then final validation reportis prepared. In 
this report it is also statedweather the cleaning process is 
validated successfully or not. Thenthe management 
finally approves the report. 
Revalidation Criteria 
25, 26 
A close view is placed to ensure that some changes can 
affect the whole cleaning process are identified and 
recorded. The changes are reviewed; if they have 
significant effect then the change proposal is made 
through the change control procedure, which is 
documented and authorized. If the change is minor or it 
has no direct effect on quality of the final product may 
be handled only by the documentation.    Revalidation is 
necessary when; 
1. The product has less solubility than the pre-
considered worst-case product. 
2.  The new drug has low potency than the pre-
considered worst case product. 
3. The equipment is change or there is any major 
modification, which can affect the contact surface 
area. 
4. The cleaning agent or its concentration is changed. 
5. The cleaning procedure is changed. 
6. The procedure gets failed during routine 
monitoring.  
Validation Reports 
The validation report is then prepared which contains 
the result, conclusion and secured approval of the study. 
The validation report includes the following: 
1. The references/summary of the method used for 
cleaning, sample and test. 
2. The analytical, physical and other observations of 
test result or reference. 
3. The final conclusion with respect to acceptability 
of the results, and the status of the procedure(s) 
being validated. 
4. If there is any a recommendation given on the 
basis of the result or information obtained during 
the study for example revalidation of process. 
5. Approval of conclusion. 





1. FDA requires, firm should have written SOPs with 
detailed cleaning procedure being used for different 
pieces of equipment. 
2. If firm is using specific cleaning procedure for 
cleaning between two different batches of the same 
product and uses a different process for cleaning 
between product changes, FDA requires the written 
procedures to address these different scenarios. 
3.  The firms should have a clear written procedure to 
remove water soluble and water insoluble residue.   
4. FDA requires the personnel responsible for 
performing and approving the study should comply 
with the acceptance criteria and the revalidation 
data. 
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5. FDA require, firms should have a validation 
protocols in written before performing the cleaning 
validation for each manufacturing machine or piece 
of equipment also carry the sampling procedures, 
and analytical methods to be used including the 
sensitivity of those methods. 
6. The firm has to conduct the validation according to 
the protocols and the results should be documented. 
7. The regulatory board has to approve the final 
validation, this express that the cleaning procedure 
is validated or not. 
CONCLUSION 
The pharmaceutical industry should be free any 
contaminationor cross contamination, it would be safe 
for the consumer. With the help of cleaning validation 
any department of pharmaceutical industry can achieve 
high degree of assurance regarding the cleaning, with 
this we can minimize any kind of contaminationor cross 
contaminationwhich ismay be any residue of previous 
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